Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pensa Pharma AB
AB
Active
Org 5567506448
Engelbrektsgatan 9, 114 32
Stockholm
Activities of agents involved in the wholesale of other particular products
·
NACE 4618
Est. 2008 · 18 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Activities of agents involved in the wholesale of other particular products
/
Pensa Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
49M
37M
24M
12M
0M
22M
2020
39M
+77%
2021
32M
-18%
2023
15M
-53%
2024
0M
-100%
2025
EBITDA
SEK millions
1M
0M
-1M
-2M
-4M
1M
2020
1M
0%
2021
-3M
-400%
2023
1M
+133%
2024
-2M
-300%
2025
Income statement
SEK thousands
Item
2020
2021
2023
2024
2025
Revenue
22 438
39 243
31 983
15 164
−87
Staff expenses
—
—
—
—
—
EBITDA
591
1 007
−3 330
1 387
−1 553
Depreciation & amort.
−73
−371
−380
−3 137
−0
EBIT
518
636
−3 710
−1 750
−1 553
Net financials
−208
439
−11
60
109
Profit before tax
439
1 076
−3 706
−1 690
−1 444
Tax
−97
−229
759
−2 932
−0
Net profit
342
847
−2 947
−4 622
−1 444
Balance sheet
SEK thousands
Item
2020
2021
2023
2024
2025
Total assets
35 258
29 118
28 604
16 979
4 215
Equity
21 622
22 127
18 333
13 711
2 267
Long-term debt
0
0
0
0
0
Short-term debt
13 637
6 991
10 271
3 268
1 948
Total debt
13 637
6 991
10 271
3 268
1 948
Financial ratios
5-year trend
EBITDA margin
-155300000.0%
This company
15.8%
Market median
982911492% below market
2020
2025
Equity ratio
53.8%
This company
38.2%
Market median
41% above market
2020
2025
Return on equity
-63.7%
This company
18.4%
Market median
446% below market
2020
2025
Net profit margin
-144400000.0%
This company
8.1%
Market median
1782716149% below market
2020
2025
Asset turnover
-0.02×
This company
1.12×
Market median
102% below market
2020
2025
Debt / equity
0.86×
This company
0.62×
Market median
39% above market
2020
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2023-03-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Pensa Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
